U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 203236

Expand all

CISATRACURIUM BESYLATE (CISATRACURIUM BESYLATE)
EQ 2MG BASE/ML
Marketing Status: Prescription
Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203236
Product Number: 001
Approval Date: Mar 30, 2018
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Prescription
Patent and Exclusivity Information
CISATRACURIUM BESYLATE (CISATRACURIUM BESYLATE)
EQ 10MG BASE/ML
Marketing Status: Prescription
Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203236
Product Number: 002
Approval Date: Mar 30, 2018
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top